ALLO•benzinga•
Allogene Granted 3 U.S. FDA Fast Track Designations For ALLO-329 For The Treatment Of Lupus, Myositis And Scleroderma
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 7, 2025 by benzinga